Zhenbiao S. Wu

No. 1, Changle East Road
Xi'an, 710032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis.

Mycophenolate mofetil plus methotrexate versus cyclophosphamide with sequential azathioprine for treatment of Takayasu arteritis.

Journal: Annals of the rheumatic diseases

Published: April 23, 2025

Risk stratification and subgroup analysis of systemic lupus erythematosus patients with pregnancy: based on a 13-year multicenter cohort study.

Risk stratification and subgroup analysis of systemic lupus erythematosus patients with pregnancy: based on a 13-year multicenter cohort study.

Journal: Clinical rheumatology

Published: March 29, 2025

Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial.

Mizoribine or Cyclophosphamide for Lupus Nephritis: A Randomized Clinical Trial.

Journal: JAMA network open

Published: March 14, 2025

The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study.

The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study.

Journal: Lupus

Published: December 23, 2024

Predictors of Cardiovascular Events in Patients With Takayasu Arteritis.

Predictors of Cardiovascular Events in Patients With Takayasu Arteritis.

Journal: The Canadian journal of cardiology

Published: December 05, 2024

Siglecs: From Biomodulation to Immunotherapy.

Siglecs: From Biomodulation to Immunotherapy.

Journal: Current protein & peptide science

Published: December 05, 2024

The conditions that patients with systemic lupus erythematosus should fulfill before pregnancy to optimize outcomes: a large-scale multicenter cohort study from China.

The conditions that patients with systemic lupus erythematosus should fulfill before pregnancy to optimize outcomes: a large-scale multicenter cohort study from China.

Journal: Arthritis research & therapy

Published: November 10, 2024

Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway.

Knockdown of SIGLEC1 inhibits osteogenic differentiation to alleviate ankylosing spondylitis progression by suppressing the TGF-β1/SMAD signaling pathway.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: June 28, 2024

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Prevalence of and risk factors for important comorbidities of systemic lupus erythematosus using data from a multicenter Chinese cohort registry: A cross-sectional study.

Journal: Clinical rheumatology

Published: May 29, 2024

Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI.

Predicting the risk of cardiovascular and cerebrovascular event in systemic lupus erythematosus: a Chinese SLE treatment and research group study XXVI.

Journal: RMD open

Published: April 16, 2024

Research of epidemiology of cardiovascular disease in China: 50 years' developments and achievements

Research of epidemiology of cardiovascular disease in China: 50 years' developments and achievements

Journal: Zhonghua xin xue guan bing za zhi

Published: November 14, 2023

Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis Registry.

Anemia and Low Body Mass Index in Axial Spondyloarthritis: Results from ChinaSpA, the Chinese Spondyloarthritis Registry.

Journal: Rheumatology and therapy

Published: October 07, 2023

Showing 1-12 of 58

Last Updated: 09/26/2026